Found 26 matching trials
Targeted Alpha Therapy With 225Actinium-Prostate Specific Membrane Antigen (PSMA)-I&T of Castration-resISTant Prostate Cancer (TATCIST). PHASE2 The treatment regimen will consist of 4 doses of FPI-2265...
Status
Active Not Recruiting
Location
XCancer Omaha/Urology Cancer Center
Learn More & Join Trial
First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC) PHASE1 Researchers are looking for a better way to treat participants who have met...
Show More Location
City of Hope - Duarte Cancer Center
Learn More & Join Trial
ACTinium in Castrate-RESistant Prostate Cancer After LUTEtium PHASE1 Advanced metastatic castration-resistant prostate cancer is a medical condi...
Show More Location
University College London Hospital
Learn More & Join Trial
Fractionated and Multiple Dose 225Ac-J591 for Progressive mCRPC PHASE1 The purpose of the initial (phase I) portion of this study is to find a dos...
Show More Status
Active Not Recruiting
Location
Brooklyn Methodist Hospital - New York Presbyterian
Learn More & Join Trial
FPI-2265 (225Ac-PSMA-I&T) for Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC) PHASE2 This is an open-label, randomized, multicenter study of FPI-2265 (225Ac-PSM...
Show More Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Learn More & Join Trial
Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer PHASE1 This is a phase I/II study investigating the combination of 225Ac-J591 (a d...
Show More Location
Dana-Farber Cancer Institute
Learn More & Join Trial
Study of 225Ac-PSMA-617 in Men With PSMA-positive Prostate Cancer PHASE1 This is a Phase 1, open-label, international, dose escalation study to eval...
Show More Status
Active Not Recruiting
Location
St. Vincent's Hospital Research Office-Translational Research Center
Learn More & Join Trial
Study With [225Ac]Ac-FL-020 in mCRPC Participants PHASE1 The purpose of this study is to evaluate the safety, therapeutic effect, an...
Show More Location
City of Hope Medical Center
Learn More & Join Trial
Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617 PHASE1 There is evidence that Actinium-225 Prostate-Specific Membrane Antigen (225...
Show More Location
University of California, San Francisco
Learn More & Join Trial
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC PHASE3 The purpose of this study is to determine whether \[225Ac\]Ac-PSMA-617 (AAA...
Show More Location
Urology Centers Of Alabama Pc
Learn More & Join Trial